Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,291 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.
Yang J, Ikezoe T, Nishioka C, Tasaka T, Taniguchi A, Kuwayama Y, Komatsu N, Bandobashi K, Togitani K, Koeffler HP, Taguchi H, Yokoyama A. Yang J, et al. Among authors: yokoyama a. Blood. 2007 Sep 15;110(6):2034-40. doi: 10.1182/blood-2007-02-073700. Epub 2007 May 10. Blood. 2007. PMID: 17495131
[Cytopathological features of multiple myeloma].
Takeuchi T, Adachi Y, Ikezoe T, Yokoyama A, Furihata M, Ohtsuki Y. Takeuchi T, et al. Among authors: yokoyama a. Nihon Rinsho. 2007 Dec;65(12):2250-5. Nihon Rinsho. 2007. PMID: 18069269 Review. Japanese.
DHMEQ, a novel nuclear factor-kappaB inhibitor, induces selective depletion of alloreactive or phytohaemagglutinin-stimulated peripheral blood mononuclear cells, decreases production of T helper type 1 cytokines, and blocks maturation of dendritic cells.
Nishioka C, Ikezoe T, Jing Y, Umezawa K, Yokoyama A. Nishioka C, et al. Among authors: yokoyama a. Immunology. 2008 Jun;124(2):198-205. doi: 10.1111/j.1365-2567.2007.02755.x. Epub 2008 Jan 23. Immunology. 2008. PMID: 18217958 Free PMC article.
1,291 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page